TIG Advisors LLC’s Alder Biopharmaceuticals ALDR Stock Holding History

TIG Advisors LLC’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,319,643	Closed	-$24.9M	–	75
2019 Q3	$24.9M	Buy	+1,319,643	New	+$15.1M	1.14%	15

TIG Advisors LLC's ALDR Position: Q4 2019 in Review

TIG Advisors LLC sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 1,319,643 shares — an estimated $24.9M sold.

TIG Advisors LLC first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $24.9M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

TIG Advisors LLC reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
TIG Advisors LLC sold 1,319,643 Alder Biopharmaceuticals shares in Q4 2019, an estimated $24.9M.
TIG Advisors LLC first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
TIG Advisors LLC's Alder Biopharmaceuticals position peaked at $24.9M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on TIG Advisors LLC's 13F filing for Q4 2019, filed 14 Feb 2020.